Rising Prevalence Of Cancer To Drive Market Growth: Transformative Forces Shaping the Oncology Biomarkers Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Oncology Biomarkers Industry Market Size Be by 2025?
In recent times, there has been a fast-paced growth in the size of the oncology biomarkers market. The market, which is projected to increase from $15.3 billion in 2024 to $17.43 billion by 2025, will experience a compound annual growth rate (CAGR) of 13.9%. Factors caused this surge within the historic period include adoption in developing nations, initiatives for precision medicine, innovations in diagnostics, support for drug development, and rising cancer incidence rates.

What's the Long-Term Growth Forecast for the Oncology Biomarkers Market Size Through 2029?
In the coming years, the oncology biomarkers market is predicted to experience swift expansion. It is forecasted to reach a value of $29.64 billion in 2029, with a compound annual growth rate (CAGR) of 14.2%. This growth during the projected period can be credited to the integration of next-generation sequencing (ngs), biomarker informatics expansion, attention on predictive pharmacogenomics, swift progression in exosome-based biomarkers, and the adoption of spatial transcriptomics. Notable trends anticipated throughout the forecast period involve standardization and quality assurance, a shift towards functional biomarkers, biomarkers' role in clinical trials, and their widened applications in immunotherapy as well as real-time treatment response monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/oncology-biomarkers-global-market-report

What Are the Key Growth Drivers Fueling the Oncology Biomarkers Market Expansion?
The growth of the oncology biomarker market is forecasted to be driven by the increasing prevalence of cancer. Cancer, a malady characterized by uncontrolled and gradual spreading of certain body cells, can be better understood through oncological biomarkers. These biomarkers offer deeper insights into the cancer type by studying the genes, proteins, and other substances present in an individual's body. For example, the National Library of Medicine, a US government institution, predicted in January 2024 that the US will see 2,001,140 new cancer cases and 611,720 cancer-related fatalities in 2024. Additionally, the yearly rise in incidence rates for cervical cancer is 1% to 2% among those aged 30 to 44 and colorectal cancer among those under 55. As such, the escalation in cancer prevalence will spur the expansion of the oncology biomarker market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12493&type=smp

What Are the Key Trends Driving Oncology Biomarkers Market Growth?
The integration of modern and trailblazing technologies is an emerging trend within the oncology biomarker market. To establish their dominance in the market, notable companies in the field are resorting to the incorporation of forward-looking technology. An illustration of this was seen in 2022 when OncoDNA, which is headquartered in Belgium and specialises in precision medicine for oncology, rolled out OncoDEEP. This unique kit allows laboratories to carry out in-depth biomarker testing. Leveraging Next-generation sequencing (NGS) technology, along with cloud-supported software tools, OncoDEEP empowers labs to conduct wide-panel sequencing, glean the molecular specifics of a tumour, scrutinize unprocessed data, and gain access to thorough quality controls.

How Is the Oncology Biomarkers Market Segmented?
The oncology biomarkers market covered in this report is segmented -

1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers
2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types
4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications
5) By End-User: Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories

Subsegments:
1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers
2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)
3) By Other Cancer Biomarkers: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12493&type=smp

Which Companies Are Leading the Charge in Oncology Biomarkers Market Innovation?
Major companies operating in the oncology biomarkers market include F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Eli Lilly and Company, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Charles River Laboratories International Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Bristol -Myers Squibb Company, Agendia Inc., Epigenomics AG, OncoDNA SA

Which Regions Are Leading the Global Oncology Biomarkers Market in Revenue?
North America was the largest region in the oncology biomarkers market in 2024. The regions covered in the oncology biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12493

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.